Skip to main content
. 2009 Mar;15(3):225–234. doi: 10.1089/acm.2008.0389

Table 4.

Secondary Physiologic Outcomes

Means ± SD
  Time Yoga (n = 14) UC (n = 15) p-Value Effect size
6MW distance (feet) Baseline 1387.9 ± 408.2 1511.0 ± 199.6    
  3 mo 1452.9 ± 406.3 1483.4 ± 229.0 0.04 0.78
Incremental cycle ergometry
 Duration (watts) Baseline 85 ± 29 72 ± 19    
  3 mo 87 ± 30 72 ± 18 0.61 0.19
Spirometry
 FEV1 % predicted Baseline 51.2 ± 10.5 44.4 ± 19.0    
  3 mo 51.2 ± 10.6 45.9 ± 20.2 0.49 0.25
 FEV1/FVC Baseline 0.46 ± 0.08 0.43 ± 0.13    
  3 mo 0.45 ± 0.06 0.44 ± 0.12 0.43 0.3
Muscle strengtha
 Hamstring strength Baseline 22.9 ± 8.8 27.21 ± 6.2    
  (flexion tq/bw 90) 3 mo 25.8 ± 9.3 28.2 ± 8.5 0.29 0.41
 Quads strength Baseline 33.1 ± 9.7 36.1 ± 12.1    
  (extension tq/bw 90) 3 mo 36.4 ± 9.9 38.9 ± 12.2 0.8 0.1
 Hamstring strength Baseline 20.3 ± 8.6 23.8 ± 5.1    
  (flexion tq/bw 180) 3 mo 22.5 ± 7.8 24.0 ± 7.1 0.19 0.52
 Quads strength Baseline 26.7 ± 10.3 26.8 ± 8.5    
  (extension tq/bw 180) 3 mo 25.9 ± 6.9 27.7 ± 9.3 0.42 0.31
a

Yoga (n = 13); UC (n = 19).

SD, standard deviation; 6MW; six-minute walk; FEV1% predicted; forced expiratory volume in 1 second, percent predicted; FEV1/FVC; ratio of forced expiratory volume in 1 second to forced vital capacity; tq/bw; torque divided by body weight.